These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30084972)

  • 61. Loss of Parkinson's disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c.
    Meng H; Yamashita C; Shiba-Fukushima K; Inoshita T; Funayama M; Sato S; Hatta T; Natsume T; Umitsu M; Takagi J; Imai Y; Hattori N
    Nat Commun; 2017 Jun; 8():15500. PubMed ID: 28589937
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients.
    Wong CH; Topp S; Gkazi AS; Troakes C; Miller JW; de Majo M; Kirby J; Shaw PJ; Morrison KE; de Belleroche J; Vance CA; Al-Chalabi A; Al-Sarraj S; Shaw CE; Smith BN
    Neurobiol Aging; 2015 Oct; 36(10):2908.e17-8. PubMed ID: 26344877
    [TBL] [Abstract][Full Text] [Related]  

  • 63. CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.
    Abdelkarim S; Morgan S; Plagnol V; Lu CH; Adamson G; Howard R; Malaspina A; Orrell R; Sharma N; Sidle K; Clarke J; Fox NC; Rossor MN; Warren JD; Clark CN; Rohrer JD; Fisher EM; Mead S; Pittman A; Fratta P
    Brain; 2016 Feb; 139(Pt 2):e9. PubMed ID: 26362910
    [No Abstract]   [Full Text] [Related]  

  • 64. High prevalence of CHCHD10 mutation in patients with frontotemporal dementia from China.
    Jiao B; Xiao T; Hou L; Gu X; Zhou Y; Zhou L; Tang B; Xu J; Shen L
    Brain; 2016 Apr; 139(Pt 4):e21. PubMed ID: 26719383
    [No Abstract]   [Full Text] [Related]  

  • 65. Analysis of the CHCHD10 gene in patients with frontotemporal dementia and amyotrophic lateral sclerosis from Spain.
    Dols-Icardo O; Nebot I; Gorostidi A; Ortega-Cubero S; Hernández I; Rojas-García R; García-Redondo A; Povedano M; Lladó A; Álvarez V; Sánchez-Juan P; Pardo J; Jericó I; Vázquez-Costa J; Sevilla T; Cardona F; Indakoechea B; Moreno F; Fernández-Torrón R; Muñoz-Llahuna L; Moreno-Grau S; Rosende-Roca M; Vela Á; Muñoz-Blanco JL; Combarros O; Coto E; Alcolea D; Fortea J; Lleó A; Sánchez-Valle R; Esteban-Pérez J; Ruiz A; Pastor P; López De Munain A; Pérez-Tur J; Clarimón J;
    Brain; 2015 Dec; 138(Pt 12):e400. PubMed ID: 26152333
    [No Abstract]   [Full Text] [Related]  

  • 66. CHCHD10
    Genin EC; di Borgo PP; Lorivel T; Hugues S; Farinelli M; Mauri-Crouzet A; Lespinasse F; Godin L; Paquis-Flucklinger V; Petit-Paitel A
    Neurobiol Dis; 2024 Jun; 195():106498. PubMed ID: 38583639
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Generation of induced pluripotent stem cell line (ZZUi007-A) from a 52-year-old patient with a novel CHCHD2 gene mutation in Parkinson's disease.
    Wang Y; Wang Z; Sun H; Mao C; Yang J; Liu Y; Liu H; Zhang S; Zhang J; Xu Y; Shi C
    Stem Cell Res; 2018 Oct; 32():87-90. PubMed ID: 30237140
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CHCHD10 variants in amyotrophic lateral sclerosis: Where is the evidence?
    Project MinE ALS Sequencing Consortium
    Ann Neurol; 2018 Jul; 84(1):110-116. PubMed ID: 30014597
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.
    Johnson JO; Glynn SM; Gibbs JR; Nalls MA; Sabatelli M; Restagno G; Drory VE; Chiò A; Rogaeva E; Traynor BJ
    Brain; 2014 Dec; 137(Pt 12):e311. PubMed ID: 25261972
    [No Abstract]   [Full Text] [Related]  

  • 70. CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
    Shi CH; Mao CY; Zhang SY; Yang J; Song B; Wu P; Zuo CT; Liu YT; Ji Y; Yang ZH; Wu J; Zhuang ZP; Xu YM
    Neurobiol Aging; 2016 Feb; 38():217.e9-217.e13. PubMed ID: 26705026
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reply: Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore D; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Dec; 137(Pt 12):e312. PubMed ID: 25261971
    [No Abstract]   [Full Text] [Related]  

  • 72. Reply: Is CHCHD10 Pro34Ser pathogenic for frontotemporal dementia and amyotrophic lateral sclerosis?
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore D; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2015 Oct; 138(Pt 10):e386. PubMed ID: 25953779
    [No Abstract]   [Full Text] [Related]  

  • 73. Mitochondrial CHCHD2: Disease-Associated Mutations, Physiological Functions, and Current Animal Models.
    Kee TR; Espinoza Gonzalez P; Wehinger JL; Bukhari MZ; Ermekbaeva A; Sista A; Kotsiviras P; Liu T; Kang DE; Woo JA
    Front Aging Neurosci; 2021; 13():660843. PubMed ID: 33967741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Genetic and pharmacologic p32-inhibition rescue CHCHD2-linked Parkinson's disease phenotypes in vivo and in cell models.
    Tio M; Wen R; Choo CN; Tan JB; Chua A; Xiao B; Sundaram JR; Chan CHS; Tan EK
    J Biomed Sci; 2024 Feb; 31(1):24. PubMed ID: 38395904
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic analysis of CHCHD2 in a southern Spanish population.
    Tejera-Parrado C; Jesús S; Huertas-Fernández I; Bernal-Bernal I; Bonilla-Toribio M; Córdoba-Tevar I; Abreu-Rodríguez I; Carrillo F; Bernal-Escudero M; Vargas-González L; Carballo M; Gómez-Garre P; Mir P
    Neurobiol Aging; 2017 Feb; 50():169.e1-169.e2. PubMed ID: 27839904
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reply: CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore D; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2015 Aug; 138(Pt 8):e373. PubMed ID: 25576309
    [No Abstract]   [Full Text] [Related]  

  • 77. Reply: Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis?
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore D; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2014 Dec; 137(Pt 12):e314. PubMed ID: 25348633
    [No Abstract]   [Full Text] [Related]  

  • 78. Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients.
    Gao C; Chen YM; Sun Q; He YC; Huang P; Wang T; Li DH; Liang L; Liu J; Xiao Q; Chen SD
    Neurobiol Aging; 2017 Jan; 49():218.e9-218.e11. PubMed ID: 27814991
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A distinct clinical phenotype in a German kindred with motor neuron disease carrying a CHCHD10 mutation.
    Kurzwelly D; Krüger S; Biskup S; Heneka MT
    Brain; 2015 Sep; 138(Pt 9):e376. PubMed ID: 25681414
    [No Abstract]   [Full Text] [Related]  

  • 80. Reply: High prevalence of CHCHD10 mutations in patients with frontotemporal dementia from China.
    Bannwarth S; Ait-El-Mkadem S; Chaussenot A; Genin EC; Lacas-Gervais S; Fragaki K; Berg-Alonso L; Kageyama Y; Serre V; Moore D; Verschueren A; Rouzier C; Le Ber I; Augé G; Cochaud C; Lespinasse F; N'Guyen K; de Septenville A; Brice A; Yu-Wai-Man P; Sesaki H; Pouget J; Paquis-Flucklinger V
    Brain; 2016 Apr; 139(Pt 4):e22. PubMed ID: 26719380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.